☰

George Kulik - Publications

Affiliations: 
 
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Alaskar A, Abdulraqeb Ali A, Hassan S, Shinwari Z, Alaiya A, von Holzen U, Miller L, Kulik G. Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells. The Prostate. PMID 36373761 DOI: 10.1002/pros.24455  0.379
2021 Ali A, Kulik G. Signaling Pathways That Control Apoptosis in Prostate Cancer. Cancers. 13. PMID 33668112 DOI: 10.3390/cancers13050937  0.379
2020 Hassan MS, Pullikuth A, Nelson KC, Flores A, Karpova Y, Baiz D, Zhu S, Sui G, Huang Y, D'Agostino R, Hemal A, von Holzen U, Debinski W, Kulik G. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR. PMID 32928910 DOI: 10.1158/1541-7786.Mcr-19-1037  0.509
2019 Kulik G. ADRB2-Targeting Therapies for Prostate Cancer. Cancers. 11. PMID 30871232 DOI: 10.3390/Cancers11030358  0.486
2018 Cantrell W, Huang Y, Menchaca AA, Kulik G, Welker ME. Synthesis and PI3 Kinase Inhibition Activity of a Wortmannin-Leucine Derivative. Molecules (Basel, Switzerland). 23. PMID 30036994 DOI: 10.3390/Molecules23071791  0.678
2018 Wright EW, Nelson RA, Karpova Y, Kulik G, Welker ME. Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines. Molecules (Basel, Switzerland). 23. PMID 29996482 DOI: 10.3390/Molecules23071675  0.681
2018 Nelson RA, Schronce T, Huang Y, Albugami A, Kulik G, Welker ME. Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. Molecules (Basel, Switzerland). 23. PMID 29973512 DOI: 10.3390/Molecules23071628  0.677
2017 Sastry KS, Chouchane AI, Wang E, Kulik G, Marincola FM, Chouchane L. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling. Cell Death & Disease. 8: e2844. PMID 28569785 DOI: 10.1038/cddis.2017.226  0.394
2016 Zhang Q, Wan M, Shi J, Horita DA, Miller LD, Kute TE, Kridel SJ, Kulik G, Sui G. Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation. Journal of Molecular Cell Biology. PMID 26762111 DOI: 10.1093/Jmcb/Mjw002  0.329
2015 Kulik G. Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network. Asian Journal of Andrology. 17: 471-4. PMID 25578933 DOI: 10.4103/1008-682X.143749  0.408
2014 Kulik G. Precision therapy to target apoptosis in prostate cancer. Experimental Oncology. 36: 226-30. PMID 25537214  0.392
2014 Sastry KS, Al-Muftah MA, Li P, Al-Kowari MK, Wang E, Ismail Chouchane A, Kizhakayil D, Kulik G, Marincola FM, Haoudi A, Chouchane L. Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells. Cell Death and Differentiation. 21: 1936-49. PMID 25215949 DOI: 10.1038/cdd.2014.140  0.319
2014 Hassan S, Karpova Y, Flores A, D'Agostino R, Danhauer SC, Hemal A, Kulik G. A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies. International Urology and Nephrology. 46: 505-10. PMID 24057680 DOI: 10.1007/S11255-013-0513-0  0.457
2013 Sun X, Bao J, Nelson KC, Li KC, Kulik G, Zhou X. Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy. Plos Computational Biology. 9: e1003358. PMID 24339759 DOI: 10.1371/journal.pcbi.1003358  0.388
2013 Hassan S, Karpova Y, Flores A, D'Agostino R, Kulik G. Surgical stress delays prostate involution in mice. Plos One. 8: e78175. PMID 24223137 DOI: 10.1371/Journal.Pone.0078175  0.433
2013 Baiz D, Hassan S, Choi YA, Flores A, Karpova Y, Yancey D, Pullikuth A, Sui G, Sadelain M, Debinski W, Kulik G. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer. Neoplasia (New York, N.Y.). 15: 1172-83. PMID 24204196 DOI: 10.1593/Neo.13986  0.566
2013 Yancey D, Nelson KC, Baiz D, Hassan S, Flores A, Pullikuth A, Karpova Y, Axanova L, Moore V, Sui G, Kulik G. BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells. Plos One. 8: e74561. PMID 24040284 DOI: 10.1371/Journal.Pone.0074561  0.557
2013 Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. The American Journal of Pathology. 183: 1339-50. PMID 23938323 DOI: 10.1016/J.Ajpath.2013.06.027  0.312
2013 Boyacioglu O, Stuart CH, Kulik G, Gmeiner WH. Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages. Molecular Therapy. Nucleic Acids. 2: e107. PMID 23860551 DOI: 10.1038/Mtna.2013.37  0.322
2013 Welker ME, Kulik G. Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 21: 4063-91. PMID 23735831 DOI: 10.1016/J.Bmc.2013.04.083  0.625
2013 Kulik G. Targeting psychoemotional stress to treat prostate cancer. Asian Journal of Andrology. 15: 362-3. PMID 23584381 DOI: 10.1038/Aja.2013.30  0.482
2013 Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R, Danial N, Datta SR, Kulik G. Behavioral stress accelerates prostate cancer development in mice. The Journal of Clinical Investigation. 123: 874-86. PMID 23348742 DOI: 10.1172/Jci63324  0.489
2013 Zhang Q, Wan M, Horita DA, Miller LD, Kridel SJ, Kute TE, Kulik G, Sui G. Abstract A25: Yin Yang 1 promotes AKT activation through direct protein binding Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A25  0.404
2012 Baiz D, Pinder TA, Hassan S, Karpova Y, Salsbury F, Welker ME, Kulik G. Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrug. Journal of Medicinal Chemistry. 55: 8038-46. PMID 22924393 DOI: 10.1021/Jm300881A  0.7
2012 Baiz D, Choi YA, Karpova Y, Yancey D, Hassan S, Sadelain M, Debinski W, Kulik G. Abstract 2748: Prostate-specific inhibition of PI3 Kinase and protein synthesis as a therapy for advanced hormone-refractory prostate cancer Cancer Research. 72: 2748-2748. DOI: 10.1158/1538-7445.Am2012-2748  0.529
2011 Baiz D, Yancey D, Choi YA, Baurin V, Karpova Y, Hassan S, Debinski W, Kulik G. Abstract 183: Loss of Bad phosphorylation and Mcl-1 expression is necessary for rapid apoptosisinduced by combination of TGFα-PE and ZSTK474 in prostate cancer cells Cancer Research. 71: 183-183. DOI: 10.1158/1538-7445.Am2011-183  0.528
2011 Hassan S, Baurin V, Karpova Y, Yancey D, Cline M, Kulik G. Abstract 10: Effect of behavioral stress on therapeutic sensitivity of prostate cancer Cancer Research. 71: 10-10. DOI: 10.1158/1538-7445.Am2011-10  0.496
2010 Hassan S, Baurin V, Karpova Y, Yancey D, Perry D, Cline M, Kulik G. Behavioral stress reduces therapeutic sensitivity of prostate cancer Brain, Behavior, and Immunity. 24: S17. DOI: 10.1016/J.Bbi.2010.07.053  0.414
2009 Smith AJ, Karpova Y, D'Agostino R, Willingham M, Kulik G. Expression of the Bcl-2 protein BAD promotes prostate cancer growth. Plos One. 4: e6224. PMID 19593445 DOI: 10.1371/Journal.Pone.0006224  0.532
2007 Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. The Journal of Clinical Investigation. 117: 1866-75. PMID 17607361 DOI: 10.1172/Jci31494  0.384
2007 Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. The Journal of Biological Chemistry. 282: 14094-100. PMID 17353197 DOI: 10.1074/Jbc.M611370200  0.432
2006 Sastry KS, Karpova Y, Kulik G. Epidermal growth factor protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways. The Journal of Biological Chemistry. 281: 27367-77. PMID 16847055 DOI: 10.1074/Jbc.M511485200  0.522
2006 Sastry KS, Smith AJ, Karpova Y, Datta SR, Kulik G. Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. The Journal of Biological Chemistry. 281: 20891-901. PMID 16728406 DOI: 10.1074/Jbc.M602928200  0.501
2002 Carson JP, Behnam M, Sutton JN, Du C, Wang X, Hunt DF, Weber MJ, Kulik G. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Research. 62: 18-23. PMID 11782351  0.346
1999 Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B. Cancer Research. 59: 1449-53. PMID 10197612  0.488
1998 Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Molecular and Cellular Biology. 18: 6711-8. PMID 9774684  0.319
1997 Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular and Cellular Biology. 17: 1595-606. PMID 9032287  0.323
Show low-probability matches.